TrialBMC pulmonary medicine2012

A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome.

Peter E Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.